Expansion of Fcγ Receptor IIIa–Positive Macrophages, Ficolin 1–Positive Monocyte‐Derived Dendritic Cells, and Plasmacytoid Dendritic Cells Associated With Severe Skin Disease in Systemic Sclerosis

Objective In this study, we sought a comprehensive understanding of myeloid cell types driving fibrosis in diffuse cutaneous systemic sclerosis (dcSSc) skin. Methods We analyzed the transcriptomes of 2,465 myeloid cells from skin biopsy specimens from 12 dcSSc patients and 10 healthy control subject...

Full description

Saved in:
Bibliographic Details
Published inArthritis & rheumatology (Hoboken, N.J.) Vol. 74; no. 2; pp. 329 - 341
Main Authors Xue, Dan, Tabib, Tracy, Morse, Christina, Yang, Yi, Domsic, Robyn T., Khanna, Dinesh, Lafyatis, Robert
Format Journal Article
LanguageEnglish
Published Boston, USA Wiley Periodicals, Inc 01.02.2022
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Objective In this study, we sought a comprehensive understanding of myeloid cell types driving fibrosis in diffuse cutaneous systemic sclerosis (dcSSc) skin. Methods We analyzed the transcriptomes of 2,465 myeloid cells from skin biopsy specimens from 12 dcSSc patients and 10 healthy control subjects using single‐cell RNA sequencing. Monocyte‐derived dendritic cells (mo‐DCs) were assessed using immunohistochemical staining and immunofluorescence analyses targeting ficolin‐1 (FCN‐1). Results A t‐distributed stochastic neighbor embedding analysis of single‐cell transcriptome data revealed 12 myeloid cell clusters, 9 of which paralleled previously described healthy control macrophage/DC clusters, and 3 of which were dcSSc‐specific myeloid cell clusters. One SSc‐associated macrophage cluster, highly expressing Fcγ receptor IIIA, was suggested on pseudotime analysis to be derived from normal CCR1+ and MARCO+ macrophages. A second SSc‐associated myeloid population highly expressed monocyte markers FCN‐1, epiregulin, S100A8, and S100A9, but was closely related to type 2 conventional DCs on pseudotime analysis and identified as mo‐DCs. Mo‐DCs were associated with more severe skin disease. Proliferating macrophages and plasmacytoid DCs were detected almost exclusively in dcSSc skin, the latter clustering with B cells and apparently derived from lymphoid progenitors. Conclusion Transcriptional signatures in these and other myeloid populations indicate innate immune system activation, possibly through Toll‐like receptors and highly up‐regulated chemokines. However, the appearance and activation of myeloid cells varies between patients, indicating potential differences in the underlying pathogenesis and/or temporal disease activity in dcSSc.
AbstractList ObjectiveIn this study, we sought a comprehensive understanding of myeloid cell types driving fibrosis in diffuse cutaneous systemic sclerosis (dcSSc) skin.MethodsWe analyzed the transcriptomes of 2,465 myeloid cells from skin biopsy specimens from 12 dcSSc patients and 10 healthy control subjects using single‐cell RNA sequencing. Monocyte‐derived dendritic cells (mo‐DCs) were assessed using immunohistochemical staining and immunofluorescence analyses targeting ficolin‐1 (FCN‐1).ResultsA t‐distributed stochastic neighbor embedding analysis of single‐cell transcriptome data revealed 12 myeloid cell clusters, 9 of which paralleled previously described healthy control macrophage/DC clusters, and 3 of which were dcSSc‐specific myeloid cell clusters. One SSc‐associated macrophage cluster, highly expressing Fcγ receptor IIIA, was suggested on pseudotime analysis to be derived from normal CCR1+ and MARCO+ macrophages. A second SSc‐associated myeloid population highly expressed monocyte markers FCN‐1, epiregulin, S100A8, and S100A9, but was closely related to type 2 conventional DCs on pseudotime analysis and identified as mo‐DCs. Mo‐DCs were associated with more severe skin disease. Proliferating macrophages and plasmacytoid DCs were detected almost exclusively in dcSSc skin, the latter clustering with B cells and apparently derived from lymphoid progenitors.ConclusionTranscriptional signatures in these and other myeloid populations indicate innate immune system activation, possibly through Toll‐like receptors and highly up‐regulated chemokines. However, the appearance and activation of myeloid cells varies between patients, indicating potential differences in the underlying pathogenesis and/or temporal disease activity in dcSSc.
Objective In this study, we sought a comprehensive understanding of myeloid cell types driving fibrosis in diffuse cutaneous systemic sclerosis (dcSSc) skin. Methods We analyzed the transcriptomes of 2,465 myeloid cells from skin biopsy specimens from 12 dcSSc patients and 10 healthy control subjects using single‐cell RNA sequencing. Monocyte‐derived dendritic cells (mo‐DCs) were assessed using immunohistochemical staining and immunofluorescence analyses targeting ficolin‐1 (FCN‐1). Results A t‐distributed stochastic neighbor embedding analysis of single‐cell transcriptome data revealed 12 myeloid cell clusters, 9 of which paralleled previously described healthy control macrophage/DC clusters, and 3 of which were dcSSc‐specific myeloid cell clusters. One SSc‐associated macrophage cluster, highly expressing Fcγ receptor IIIA, was suggested on pseudotime analysis to be derived from normal CCR1+ and MARCO+ macrophages. A second SSc‐associated myeloid population highly expressed monocyte markers FCN‐1, epiregulin, S100A8, and S100A9, but was closely related to type 2 conventional DCs on pseudotime analysis and identified as mo‐DCs. Mo‐DCs were associated with more severe skin disease. Proliferating macrophages and plasmacytoid DCs were detected almost exclusively in dcSSc skin, the latter clustering with B cells and apparently derived from lymphoid progenitors. Conclusion Transcriptional signatures in these and other myeloid populations indicate innate immune system activation, possibly through Toll‐like receptors and highly up‐regulated chemokines. However, the appearance and activation of myeloid cells varies between patients, indicating potential differences in the underlying pathogenesis and/or temporal disease activity in dcSSc.
In this study, we sought a comprehensive understanding of myeloid cell types driving fibrosis in diffuse cutaneous systemic sclerosis (dcSSc) skin.OBJECTIVEIn this study, we sought a comprehensive understanding of myeloid cell types driving fibrosis in diffuse cutaneous systemic sclerosis (dcSSc) skin.We analyzed the transcriptomes of 2,465 myeloid cells from skin biopsy specimens from 12 dcSSc patients and 10 healthy control subjects using single-cell RNA sequencing. Monocyte-derived dendritic cells (mo-DCs) were assessed using immunohistochemical staining and immunofluorescence analyses targeting ficolin-1 (FCN-1).METHODSWe analyzed the transcriptomes of 2,465 myeloid cells from skin biopsy specimens from 12 dcSSc patients and 10 healthy control subjects using single-cell RNA sequencing. Monocyte-derived dendritic cells (mo-DCs) were assessed using immunohistochemical staining and immunofluorescence analyses targeting ficolin-1 (FCN-1).A t-distributed stochastic neighbor embedding analysis of single-cell transcriptome data revealed 12 myeloid cell clusters, 9 of which paralleled previously described healthy control macrophage/DC clusters, and 3 of which were dcSSc-specific myeloid cell clusters. One SSc-associated macrophage cluster, highly expressing Fcγ receptor IIIA, was suggested on pseudotime analysis to be derived from normal CCR1+ and MARCO+ macrophages. A second SSc-associated myeloid population highly expressed monocyte markers FCN-1, epiregulin, S100A8, and S100A9, but was closely related to type 2 conventional DCs on pseudotime analysis and identified as mo-DCs. Mo-DCs were associated with more severe skin disease. Proliferating macrophages and plasmacytoid DCs were detected almost exclusively in dcSSc skin, the latter clustering with B cells and apparently derived from lymphoid progenitors.RESULTSA t-distributed stochastic neighbor embedding analysis of single-cell transcriptome data revealed 12 myeloid cell clusters, 9 of which paralleled previously described healthy control macrophage/DC clusters, and 3 of which were dcSSc-specific myeloid cell clusters. One SSc-associated macrophage cluster, highly expressing Fcγ receptor IIIA, was suggested on pseudotime analysis to be derived from normal CCR1+ and MARCO+ macrophages. A second SSc-associated myeloid population highly expressed monocyte markers FCN-1, epiregulin, S100A8, and S100A9, but was closely related to type 2 conventional DCs on pseudotime analysis and identified as mo-DCs. Mo-DCs were associated with more severe skin disease. Proliferating macrophages and plasmacytoid DCs were detected almost exclusively in dcSSc skin, the latter clustering with B cells and apparently derived from lymphoid progenitors.Transcriptional signatures in these and other myeloid populations indicate innate immune system activation, possibly through Toll-like receptors and highly up-regulated chemokines. However, the appearance and activation of myeloid cells varies between patients, indicating potential differences in the underlying pathogenesis and/or temporal disease activity in dcSSc.CONCLUSIONTranscriptional signatures in these and other myeloid populations indicate innate immune system activation, possibly through Toll-like receptors and highly up-regulated chemokines. However, the appearance and activation of myeloid cells varies between patients, indicating potential differences in the underlying pathogenesis and/or temporal disease activity in dcSSc.
In this study, we sought a comprehensive understanding of myeloid cell types driving fibrosis in diffuse cutaneous systemic sclerosis (dcSSc) skin. We analyzed the transcriptomes of 2,465 myeloid cells from skin biopsy specimens from 12 dcSSc patients and 10 healthy control subjects using single-cell RNA sequencing. Monocyte-derived dendritic cells (mo-DCs) were assessed using immunohistochemical staining and immunofluorescence analyses targeting ficolin-1 (FCN-1). A t-distributed stochastic neighbor embedding analysis of single-cell transcriptome data revealed 12 myeloid cell clusters, 9 of which paralleled previously described healthy control macrophage/DC clusters, and 3 of which were dcSSc-specific myeloid cell clusters. One SSc-associated macrophage cluster, highly expressing Fcγ receptor IIIA, was suggested on pseudotime analysis to be derived from normal CCR1+ and MARCO+ macrophages. A second SSc-associated myeloid population highly expressed monocyte markers FCN-1, epiregulin, S100A8, and S100A9, but was closely related to type 2 conventional DCs on pseudotime analysis and identified as mo-DCs. Mo-DCs were associated with more severe skin disease. Proliferating macrophages and plasmacytoid DCs were detected almost exclusively in dcSSc skin, the latter clustering with B cells and apparently derived from lymphoid progenitors. Transcriptional signatures in these and other myeloid populations indicate innate immune system activation, possibly through Toll-like receptors and highly up-regulated chemokines. However, the appearance and activation of myeloid cells varies between patients, indicating potential differences in the underlying pathogenesis and/or temporal disease activity in dcSSc.
Author Xue, Dan
Tabib, Tracy
Lafyatis, Robert
Khanna, Dinesh
Domsic, Robyn T.
Morse, Christina
Yang, Yi
Author_xml – sequence: 1
  givenname: Dan
  surname: Xue
  fullname: Xue, Dan
  organization: University of Pittsburgh, Pittsburgh, Pennsylvania, and Xiangya Hospital, Central South University
– sequence: 2
  givenname: Tracy
  surname: Tabib
  fullname: Tabib, Tracy
  organization: University of Pittsburgh
– sequence: 3
  givenname: Christina
  surname: Morse
  fullname: Morse, Christina
  organization: University of Pittsburgh
– sequence: 4
  givenname: Yi
  surname: Yang
  fullname: Yang, Yi
  organization: Xiangya Hospital, Central South University
– sequence: 5
  givenname: Robyn T.
  orcidid: 0000-0002-2765-0922
  surname: Domsic
  fullname: Domsic, Robyn T.
  organization: University of Pittsburgh
– sequence: 6
  givenname: Dinesh
  orcidid: 0000-0003-1412-4453
  surname: Khanna
  fullname: Khanna, Dinesh
  organization: University of Michigan
– sequence: 7
  givenname: Robert
  orcidid: 0000-0002-9398-5034
  surname: Lafyatis
  fullname: Lafyatis, Robert
  email: lafyatis@pitt.edu
  organization: University of Pittsburgh
BackLink https://www.ncbi.nlm.nih.gov/pubmed/34042322$$D View this record in MEDLINE/PubMed
BookMark eNp1ks9uEzEQxleoiJbSAy-ALHEBibT-s95dH6OkgUhFVE0RR8vrTKjL7nqxnba59RGQeBQeA4mH6JMwkORAAV888vy-zyPN9zjb6XwHWfaU0UNGKT8yIR3mrGLiQbbHBS8GklO5s62ZYrvZQYyXFI8qaUHlo2xX5DTHPt_Lvh_f9KaLznfEL8jE_vhGzsBCn3wg0-nU3N1-PfXRJXcF5K2xwfcX5iPEV2TirG9cR9gfhO-8XSW4u_0yhoAvczKGbh6wa8kImgaFppuT08bE1iDp3V8EGcborTMJxR9cuiAzuIIAZPYJfxu7CCYCwXK2iglaVM1sAwEniE-yhwvTRDjY3PvZ-8nx-ejN4OTd6-loeDKwoqrEQNRAeS5oKZksy0LJWlRQ1sqovCxlyctaCsnLRV0LygqjBMfC5IzK3AJYJfazF2vfPvjPS4hJty5anN104JdRcymEYFWuCkSf30Mv_TJ0OJ3mBedKSqkYUs821LJuYa774FoTVnq7JgSO1gAuIMYAC21dMgm3loJxjWZU_8qCxizo31lAxct7iq3pv9iN-7VrYPV_UA_PzteKn-w7xuI
CitedBy_id crossref_primary_10_1016_j_celrep_2024_113977
crossref_primary_10_1016_j_mam_2024_101252
crossref_primary_10_1093_rheumatology_keac410
crossref_primary_10_1002_art_42536
crossref_primary_10_3389_fimmu_2024_1430825
crossref_primary_10_1093_rheumatology_keae517
crossref_primary_10_1016_j_isci_2023_106653
crossref_primary_10_1038_s41392_025_02124_y
crossref_primary_10_1016_j_lfs_2022_121238
crossref_primary_10_1002_path_5984
crossref_primary_10_1186_s10020_024_01047_8
crossref_primary_10_1186_s12951_023_01921_3
crossref_primary_10_3389_fimmu_2023_1219487
crossref_primary_10_1016_j_jid_2023_09_288
crossref_primary_10_1038_s41577_024_01043_3
crossref_primary_10_1016_j_clindermatol_2024_12_007
crossref_primary_10_1038_s41392_022_01070_3
crossref_primary_10_2147_PTT_S492205
crossref_primary_10_1038_s41467_023_41328_0
crossref_primary_10_1177_25152564241291374
crossref_primary_10_1002_art_43044
crossref_primary_10_31083_j_fbs1504016
crossref_primary_10_3389_fimmu_2022_1051254
crossref_primary_10_1016_j_xcrm_2024_101399
crossref_primary_10_1038_s41392_023_01501_9
crossref_primary_10_1002_art_42247
crossref_primary_10_1007_s12016_023_08969_x
crossref_primary_10_1093_rheumatology_keac421
crossref_primary_10_1038_s41592_024_02175_z
crossref_primary_10_1093_rheumatology_keae688
crossref_primary_10_1002_art_42662
crossref_primary_10_1152_ajpcell_00813_2024
crossref_primary_10_3390_biomedicines10020316
crossref_primary_10_3390_ijms25179182
crossref_primary_10_1002_ctm2_1545
crossref_primary_10_1038_s41584_022_00864_7
crossref_primary_10_3389_fphar_2022_826839
crossref_primary_10_1097_j_pain_0000000000003106
crossref_primary_10_3389_fmed_2021_822804
crossref_primary_10_1016_j_pharmthera_2025_108807
crossref_primary_10_1016_j_jaut_2023_103097
crossref_primary_10_1097_j_pain_0000000000003107
crossref_primary_10_1097_BOR_0000000000001047
crossref_primary_10_1038_s41584_022_00803_6
crossref_primary_10_3389_fimmu_2023_1240800
crossref_primary_10_1016_j_autrev_2024_103637
crossref_primary_10_1002_art_42380
crossref_primary_10_3389_fimmu_2024_1452801
Cites_doi 10.1038/s41590-018-0136-9
10.1038/s41467-021-24607-6
10.1002/art.38288
10.1016/j.jid.2017.09.045
10.1016/S0140-6736(17)30933-9
10.1038/nbt.2859
10.1002/art.40455
10.1146/annurev-immunol-051116-052215
10.3389/fimmu.2019.01222
10.1038/s41467-019-09683-z
10.1016/j.ajpath.2010.08.003
10.1002/art.39289
10.1038/jid.2011.472
10.1038/s41577-018-0029-z
10.1084/jem.20190811
10.1002/art.39287
10.1136/annrheumdis-2018-214865
10.1186/ar3066
10.1126/scitranslmed.aam8458
10.1371/journal.pone.0002696
10.1038/jid.2010.200
10.1038/s41592-019-0619-0
10.1016/j.imlet.2017.11.003
10.1111/imm.12888
10.1183/13993003.02441-2018
10.1056/NEJMoa1114576
10.1007/s11926-019-0831-z
10.1136/ard.2010.132464
10.1038/nbt.4096
10.1002/art.22382
10.1371/journal.pone.0001452
10.1126/science.aah4573
10.1189/jlb.1A0314-170R
10.1172/jci.insight.98850
10.1159/000163933
10.1136/annrheumdis-2012-202814
10.1186/ar4598
10.1016/j.jdermsci.2019.11.012
10.1089/wound.2017.0732
10.1016/S0140-6736(16)00232-4
ContentType Journal Article
Copyright 2021, American College of Rheumatology
2021, American College of Rheumatology.
2022 American College of Rheumatology
Copyright_xml – notice: 2021, American College of Rheumatology
– notice: 2021, American College of Rheumatology.
– notice: 2022 American College of Rheumatology
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QL
7QP
7T5
7TM
7U7
C1K
H94
K9.
7X8
DOI 10.1002/art.41813
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Bacteriology Abstracts (Microbiology B)
Calcium & Calcified Tissue Abstracts
Immunology Abstracts
Nucleic Acids Abstracts
Toxicology Abstracts
Environmental Sciences and Pollution Management
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Toxicology Abstracts
Bacteriology Abstracts (Microbiology B)
Nucleic Acids Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Immunology Abstracts
Calcium & Calcified Tissue Abstracts
Environmental Sciences and Pollution Management
MEDLINE - Academic
DatabaseTitleList Toxicology Abstracts

MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2326-5205
EndPage 341
ExternalDocumentID 34042322
10_1002_art_41813
ART41813
Genre article
Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: China Scholarship Council (CSC)
  funderid: 201706370258
– fundername: National Institute of Arthritis and Musculoskeletal and Skin Diseases
  funderid: P50AR060780
– fundername: NIAMS NIH HHS
  grantid: R61 AR076819
– fundername: NIAMS NIH HHS
  grantid: P50 AR060780
– fundername: NIAMS NIH HHS
  grantid: P50AR060780
– fundername: China Scholarship Council (CSC)
  grantid: 201706370258
GroupedDBID 0R~
1OC
24P
33P
3SF
4.4
52O
52U
52V
53G
5VS
AAESR
AAEVG
AAHHS
AAHQN
AAIPD
AAMNL
AANHP
AANLZ
AAQQT
AASGY
AAWTL
AAXRX
AAYCA
AAZKR
ABCUV
ABJNI
ABLJU
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACFBH
ACGFS
ACGOF
ACIWK
ACMXC
ACPOU
ACPRK
ACRPL
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFPM
AFGKR
AFPWT
AFRAH
AFWVQ
AFZJQ
AHBTC
AHMBA
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ATUGU
AZFZN
AZVAB
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
DCZOG
DIK
DRFUL
DRMAN
DRSTM
EBS
EJD
EMOBN
EX3
F00
FUBAC
G-S
G.N
GODZA
HGLYW
KBYEO
LATKE
LEEKS
LH4
LITHE
LOXES
LUTES
LW6
LYRES
MEWTI
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
NF~
O66
O9-
OK1
OVD
P2W
PQQKQ
QB0
ROL
SUPJJ
SV3
TEORI
V9Y
WBKPD
WHWMO
WIH
WIJ
WIK
WOHZO
WVDHM
WXSBR
YCJ
AAFWJ
AAYXX
AEYWJ
AGHNM
AGQPQ
AGYGG
CITATION
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
CGR
CUY
CVF
ECM
EIF
NPM
7QL
7QP
7T5
7TM
7U7
C1K
H94
K9.
7X8
ID FETCH-LOGICAL-c3883-3be02430751577695b38e7b9a94775727b53527fbb3016a932b30a41054ceec93
ISSN 2326-5191
2326-5205
IngestDate Fri Jul 11 09:31:46 EDT 2025
Fri Jul 25 12:19:30 EDT 2025
Mon Jul 21 06:02:22 EDT 2025
Tue Jul 01 00:56:03 EDT 2025
Thu Apr 24 23:08:26 EDT 2025
Wed Jan 22 16:26:24 EST 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Language English
License 2021, American College of Rheumatology.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c3883-3be02430751577695b38e7b9a94775727b53527fbb3016a932b30a41054ceec93
Notes Supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH (grant 2P50‐AR‐060780) and by an unrestricted grant from Pfizer. Dr. Xue's work was supported by the China Scholarship Council (grant 201706370258).
Dr. Domsic has received consulting fees from Eicos Sciences and Boehringer‐Ingelheim (less than $10,000 each). Dr. Khanna has received consulting fees from Actelion, Acceleron, Bristol Myers Squibb, Blade Therapeutics, Bayer, ChemomAB, Cytori, Celgene, Curzion, Corbus Pharmaceuticals, CSL Behring, GlaxoSmithKline, Genentech, Mitsubishi Tanabe Pharma Development America, Sanofi‐Aventis, and UCB (less than $10,000 each) and from Eicos Sciences, Horizon, and Boehringer Ingelheim (more than $10,000 each), has received grant support from Bristol Myers Squibb, Pfizer, Bayer, and Horizon, and owns stock or stock options in Eicos Sciences and CiviBio Pharma. Dr. Lafyatis has received consulting fees from Bristol Myers Squibb, Formation, Sanofi, Biocon, Boehringer‐Mannheim, Merck, and Genentech/Roche (less than $10,000 each) and research grants from Corbus, Formation, Elpidera, Regeneron, Pfizer, and Kiniksa. No other disclosures relevant to this article were reported.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-2765-0922
0000-0002-9398-5034
0000-0003-1412-4453
OpenAccessLink https://hdl.handle.net/2027.42/171515
PMID 34042322
PQID 2622955591
PQPubID 946334
PageCount 13
ParticipantIDs proquest_miscellaneous_2533318496
proquest_journals_2622955591
pubmed_primary_34042322
crossref_citationtrail_10_1002_art_41813
crossref_primary_10_1002_art_41813
wiley_primary_10_1002_art_41813_ART41813
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate February 2022
2022-02-00
20220201
PublicationDateYYYYMMDD 2022-02-01
PublicationDate_xml – month: 02
  year: 2022
  text: February 2022
PublicationDecade 2020
PublicationPlace Boston, USA
PublicationPlace_xml – name: Boston, USA
– name: United States
– name: Atlanta
PublicationTitle Arthritis & rheumatology (Hoboken, N.J.)
PublicationTitleAlternate Arthritis Rheumatol
PublicationYear 2022
Publisher Wiley Periodicals, Inc
Wiley Subscription Services, Inc
Publisher_xml – name: Wiley Periodicals, Inc
– name: Wiley Subscription Services, Inc
References 2010; 12
2017; 6
2019; 54
2019; 10
2015; 97
2019; 78
2017; 390
2019; 16
2016; 387
1992; 19
2014; 370
2008; 3
2007; 56
2017; 356
2011; 178
2014; 66
2019; 154635
1995; 63
2015; 67
2018; 19
2018; 18
2018; 154
2018; 3
2012; 132
2018; 195
2021; 12
2020; 97
2018; 138
2019; 21
2011; 70
2017; 35
2018; 70
2014; 16
2020; 217
2010; 130
2014; 73
2018; 10
2014; 32
2018; 36
e_1_2_7_6_1
e_1_2_7_4_1
e_1_2_7_3_1
e_1_2_7_9_1
e_1_2_7_8_1
e_1_2_7_7_1
e_1_2_7_19_1
e_1_2_7_18_1
e_1_2_7_17_1
e_1_2_7_16_1
e_1_2_7_40_1
e_1_2_7_2_1
e_1_2_7_15_1
Skaug B (e_1_2_7_30_1) 2019; 154635
e_1_2_7_41_1
e_1_2_7_14_1
e_1_2_7_42_1
e_1_2_7_13_1
e_1_2_7_43_1
e_1_2_7_12_1
e_1_2_7_11_1
e_1_2_7_10_1
e_1_2_7_26_1
Ishikawa O (e_1_2_7_5_1) 1992; 19
e_1_2_7_27_1
e_1_2_7_28_1
e_1_2_7_29_1
e_1_2_7_25_1
e_1_2_7_31_1
e_1_2_7_24_1
e_1_2_7_32_1
e_1_2_7_23_1
e_1_2_7_33_1
e_1_2_7_22_1
e_1_2_7_34_1
e_1_2_7_21_1
e_1_2_7_35_1
e_1_2_7_20_1
e_1_2_7_36_1
e_1_2_7_37_1
e_1_2_7_38_1
e_1_2_7_39_1
35644033 - Arthritis Rheumatol. 2022 Oct;74(10):1721-1722
References_xml – volume: 390
  start-page: 1685
  year: 2017
  end-page: 99
  article-title: Systemic sclerosis [review]
  publication-title: Lancet
– volume: 10
  start-page: 1731
  year: 2019
  article-title: CXCL4 assembles DNA into liquid crystalline complexes to amplify TLR9‐mediated interferon‐α production in systemic sclerosis
  publication-title: Nat Commun
– volume: 12
  year: 2021
  article-title: Myofibroblast transcriptome indicates SFRP2(hi) fibroblast progenitors in systemic sclerosis skin
  publication-title: Nat Commun
– volume: 6
  start-page: 356
  year: 2017
  end-page: 69
  article-title: Toll‐like receptor‐4 signaling drives persistent fibroblast activation and prevents fibrosis resolution in scleroderma [review]
  publication-title: Adv Wound Care (New Rochelle)
– volume: 16
  start-page: R136
  year: 2014
  article-title: Chronic Toll‐like receptor 4 stimulation in skin induces inflammation, macrophage activation, transforming growth factor β signature gene expression, and fibrosis
  publication-title: Arthritis Res Ther
– volume: 217
  year: 2020
  article-title: Re‐evaluation of human BDCA‐2+ DC during acute sterile skin inflammation
  publication-title: J Exp Med
– volume: 130
  start-page: 2583
  year: 2010
  end-page: 93
  article-title: Poly(I:C) drives type I IFN‐ and TGFβ‐mediated inflammation and dermal fibrosis simulating altered gene expression in systemic sclerosis
  publication-title: J Invest Dermatol
– volume: 56
  start-page: 1010
  year: 2007
  end-page: 20
  article-title: A macrophage marker, Siglec‐1, is increased on circulating monocytes in patients with systemic sclerosis and induced by type I interferons and toll‐like receptor agonists
  publication-title: Arthritis Rheum
– volume: 10
  year: 2018
  article-title: Plasmacytoid dendritic cells promote systemic sclerosis with a key role for TLR8
  publication-title: Sci Transl Med
– volume: 66
  start-page: 714
  year: 2014
  end-page: 25
  article-title: Association of interferon‐ and transforming growth factor β–regulated genes and macrophage activation with systemic sclerosis–related progressive lung fibrosis
  publication-title: Arthritis Rheumatol
– volume: 3
  year: 2008
  article-title: Molecular subsets in the gene expression signatures of scleroderma skin
  publication-title: PloS One
– volume: 10
  start-page: 1222
  year: 2019
  article-title: What makes a pDC: recent advances in understanding plasmacytoid DC development and heterogeneity [review]
  publication-title: Front Immunol
– volume: 154
  start-page: 3
  year: 2018
  end-page: 20
  article-title: Human dendritic cell subsets: an update [review]
  publication-title: Immunology
– volume: 3
  year: 2018
  article-title: TLR4‐dependent fibroblast activation drives persistent organ fibrosis in skin and lung
  publication-title: JCI Insight
– volume: 73
  start-page: 1864
  year: 2014
  end-page: 72
  article-title: Global chemokine expression in systemic sclerosis (SSc): CCL19 expression correlates with vascular inflammation in SSc skin
  publication-title: Ann Rheum Dis
– volume: 16
  start-page: 1289
  year: 2019
  end-page: 96
  article-title: Fast, sensitive and accurate integration of single‐cell data with Harmony
  publication-title: Nat Methods
– volume: 138
  start-page: 802
  year: 2018
  end-page: 10
  article-title: SFRP2/DPP4 and FMO1/LSP1 define major fibroblast populations in human skin
  publication-title: J Invest Dermatol
– volume: 19
  start-page: 711
  year: 2018
  end-page: 22
  article-title: Distinct progenitor lineages contribute to the heterogeneity of plasmacytoid dendritic cells
  publication-title: Nat Immunol
– volume: 18
  start-page: 545
  year: 2018
  end-page: 58
  article-title: IFNγ: signalling, epigenetics and roles in immunity, metabolism, disease and cancer immunotherapy [review]
  publication-title: Nat Rev Immunol
– volume: 21
  start-page: 31
  year: 2019
  article-title: Macrophages in systemic sclerosis: novel insights and therapeutic implications [review]
  publication-title: Curr Rheumatol Rep
– volume: 356
  year: 2017
  article-title: Single‐cell RNA‐seq reveals new types of human blood dendritic cells, monocytes, and progenitors
  publication-title: Science
– volume: 3
  year: 2008
  article-title: Capillary regeneration in scleroderma: stem cell therapy reverses phenotype?
  publication-title: PloS One
– volume: 370
  start-page: 433
  year: 2014
  end-page: 43
  article-title: Proteome‐wide analysis and CXCL4 as a biomarker in systemic sclerosis
  publication-title: N Engl J Med
– volume: 32
  start-page: 381
  year: 2014
  end-page: 6
  article-title: The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells [letter]
  publication-title: Nat Biotechnol
– volume: 195
  start-page: 18
  year: 2018
  end-page: 29
  article-title: Dendritic cells in systemic sclerosis: advances from human and mice studies [review]
  publication-title: Immunol Lett
– volume: 12
  start-page: R128
  year: 2010
  article-title: Characterization of monocyte/macrophage subsets in the skin and peripheral blood derived from patients with systemic sclerosis
  publication-title: Arthritis Res Ther
– volume: 387
  start-page: 2630
  year: 2016
  end-page: 40
  article-title: Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial
  publication-title: Lancet
– volume: 19
  start-page: 1202
  year: 1992
  end-page: 6
  article-title: Macrophage infiltration in the skin of patients with systemic sclerosis
  publication-title: J Rheumatol
– volume: 67
  start-page: 3016
  year: 2015
  end-page: 26
  article-title: Dissecting the heterogeneity of skin gene expression patterns in systemic sclerosis
  publication-title: Arthritis Rheumatol
– volume: 97
  start-page: 41
  year: 2020
  end-page: 9
  article-title: Transcriptome landscape of myeloid cells in human skin reveals diversity, rare populations and putative DC progenitors
  publication-title: J Dermatol Sci
– volume: 70
  start-page: 912
  year: 2018
  end-page: 9
  article-title: Skin gene expression is prognostic for the trajectory of skin disease in patients with diffuse cutaneous systemic sclerosis
  publication-title: Arthritis Rheumatol
– volume: 67
  start-page: 3004
  year: 2015
  end-page: 15
  article-title: A longitudinal biomarker for the extent of skin disease in patients with diffuse cutaneous systemic sclerosis
  publication-title: Arthritis Rheumatol
– volume: 154635
  year: 2019
  article-title: Type I interferon dysregulation in systemic sclerosis [review]
  publication-title: Cytokine
– volume: 132
  start-page: 1363
  year: 2012
  end-page: 73
  article-title: Intrinsic gene expression subsets of diffuse cutaneous systemic sclerosis are stable in serial skin biopsies
  publication-title: J Invest Dermatol
– volume: 36
  start-page: 411
  year: 2018
  end-page: 20
  article-title: Integrating single‐cell transcriptomic data across different conditions, technologies, and species
  publication-title: Nat Biotechnol
– volume: 78
  start-page: 1379
  year: 2019
  end-page: 87
  article-title: Single‐cell analysis reveals fibroblast heterogeneity and myofibroblasts in systemic sclerosis‐associated interstitial lung disease
  publication-title: Ann Rheum Dis
– volume: 63
  start-page: 48
  year: 1995
  end-page: 56
  article-title: Mononuclear cellular infiltrates in clinically involved skin from patients with systemic sclerosis of recent onset predominantly consist of monocytes/macrophages
  publication-title: Pathobiology
– volume: 178
  start-page: 19
  year: 2011
  end-page: 25
  article-title: Wound macrophages as key regulators of repair: origin, phenotype, and function [review]
  publication-title: Am J Pathol
– volume: 97
  start-page: 61
  year: 2015
  end-page: 9
  article-title: The chemotaxis of M1 and M2 macrophages is regulated by different chemokines
  publication-title: J Leukoc Biol
– volume: 35
  start-page: 469
  year: 2017
  end-page: 99
  article-title: Antigen‐presenting cells in the skin [review]
  publication-title: Annu Rev Immunol
– volume: 70
  start-page: 544
  year: 2011
  end-page: 50
  article-title: dsRNA activation of endothelin‐1 and markers of vascular activation in endothelial cells and fibroblasts
  publication-title: Ann Rheum Dis
– volume: 54
  year: 2019
  article-title: Proliferating SPP1/MERTK‐expressing macrophages in idiopathic pulmonary fibrosis
  publication-title: Eur Respir J
– ident: e_1_2_7_41_1
  doi: 10.1038/s41590-018-0136-9
– ident: e_1_2_7_20_1
  doi: 10.1038/s41467-021-24607-6
– ident: e_1_2_7_11_1
  doi: 10.1002/art.38288
– ident: e_1_2_7_19_1
  doi: 10.1016/j.jid.2017.09.045
– ident: e_1_2_7_2_1
  doi: 10.1016/S0140-6736(17)30933-9
– ident: e_1_2_7_25_1
  doi: 10.1038/nbt.2859
– ident: e_1_2_7_24_1
  doi: 10.1002/art.40455
– ident: e_1_2_7_31_1
  doi: 10.1146/annurev-immunol-051116-052215
– ident: e_1_2_7_42_1
  doi: 10.3389/fimmu.2019.01222
– ident: e_1_2_7_40_1
  doi: 10.1038/s41467-019-09683-z
– ident: e_1_2_7_43_1
  doi: 10.1016/j.ajpath.2010.08.003
– ident: e_1_2_7_14_1
  doi: 10.1002/art.39289
– ident: e_1_2_7_33_1
  doi: 10.1038/jid.2011.472
– ident: e_1_2_7_23_1
  doi: 10.1038/s41577-018-0029-z
– ident: e_1_2_7_32_1
  doi: 10.1084/jem.20190811
– ident: e_1_2_7_12_1
  doi: 10.1002/art.39287
– ident: e_1_2_7_39_1
  doi: 10.1136/annrheumdis-2018-214865
– volume: 154635
  year: 2019
  ident: e_1_2_7_30_1
  article-title: Type I interferon dysregulation in systemic sclerosis [review]
  publication-title: Cytokine
– ident: e_1_2_7_8_1
  doi: 10.1186/ar3066
– ident: e_1_2_7_15_1
  doi: 10.1126/scitranslmed.aam8458
– ident: e_1_2_7_13_1
  doi: 10.1371/journal.pone.0002696
– ident: e_1_2_7_36_1
  doi: 10.1038/jid.2010.200
– ident: e_1_2_7_22_1
  doi: 10.1038/s41592-019-0619-0
– ident: e_1_2_7_4_1
  doi: 10.1016/j.imlet.2017.11.003
– ident: e_1_2_7_27_1
  doi: 10.1111/imm.12888
– ident: e_1_2_7_38_1
  doi: 10.1183/13993003.02441-2018
– ident: e_1_2_7_17_1
  doi: 10.1056/NEJMoa1114576
– ident: e_1_2_7_3_1
  doi: 10.1007/s11926-019-0831-z
– ident: e_1_2_7_35_1
  doi: 10.1136/ard.2010.132464
– ident: e_1_2_7_26_1
  doi: 10.1038/nbt.4096
– ident: e_1_2_7_7_1
  doi: 10.1002/art.22382
– ident: e_1_2_7_16_1
  doi: 10.1371/journal.pone.0001452
– ident: e_1_2_7_21_1
  doi: 10.1126/science.aah4573
– ident: e_1_2_7_10_1
  doi: 10.1189/jlb.1A0314-170R
– volume: 19
  start-page: 1202
  year: 1992
  ident: e_1_2_7_5_1
  article-title: Macrophage infiltration in the skin of patients with systemic sclerosis
  publication-title: J Rheumatol
– ident: e_1_2_7_29_1
  doi: 10.1172/jci.insight.98850
– ident: e_1_2_7_6_1
  doi: 10.1159/000163933
– ident: e_1_2_7_9_1
  doi: 10.1136/annrheumdis-2012-202814
– ident: e_1_2_7_28_1
  doi: 10.1186/ar4598
– ident: e_1_2_7_18_1
  doi: 10.1016/j.jdermsci.2019.11.012
– ident: e_1_2_7_34_1
  doi: 10.1089/wound.2017.0732
– ident: e_1_2_7_37_1
  doi: 10.1016/S0140-6736(16)00232-4
– reference: 35644033 - Arthritis Rheumatol. 2022 Oct;74(10):1721-1722
SSID ssj0000970605
Score 2.578394
Snippet Objective In this study, we sought a comprehensive understanding of myeloid cell types driving fibrosis in diffuse cutaneous systemic sclerosis (dcSSc) skin....
In this study, we sought a comprehensive understanding of myeloid cell types driving fibrosis in diffuse cutaneous systemic sclerosis (dcSSc) skin. We analyzed...
ObjectiveIn this study, we sought a comprehensive understanding of myeloid cell types driving fibrosis in diffuse cutaneous systemic sclerosis (dcSSc)...
In this study, we sought a comprehensive understanding of myeloid cell types driving fibrosis in diffuse cutaneous systemic sclerosis (dcSSc) skin.OBJECTIVEIn...
SourceID proquest
pubmed
crossref
wiley
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 329
SubjectTerms Biopsy
CC chemokine receptors
CCR1 protein
Cell activation
Chemokines
Clustering
Dendritic cells
Dendritic Cells - immunology
Dendritic structure
Embedding
Fibrosis
Ficolins
Gene sequencing
Humans
Immune system
Immunofluorescence
Innate immunity
Lectins - biosynthesis
Lectins - immunology
Lymphocytes B
Macrophages
Macrophages - immunology
Macrophages - metabolism
MARCO protein
Monocytes
Monocytes - immunology
Monocytes - metabolism
Myeloid cells
Pathogenesis
Progenitor cells
Receptors
Receptors, IgG - biosynthesis
Receptors, IgG - immunology
Scleroderma
Scleroderma, Diffuse - immunology
Severity of Illness Index
Skin diseases
Systemic sclerosis
Transcription
Transcriptomes
Title Expansion of Fcγ Receptor IIIa–Positive Macrophages, Ficolin 1–Positive Monocyte‐Derived Dendritic Cells, and Plasmacytoid Dendritic Cells Associated With Severe Skin Disease in Systemic Sclerosis
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fart.41813
https://www.ncbi.nlm.nih.gov/pubmed/34042322
https://www.proquest.com/docview/2622955591
https://www.proquest.com/docview/2533318496
Volume 74
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3ZbtNAFB21RUK8IHYCBQ0VlZBSB3vGS_xY0kRJaUulpiI8WZ7JRIkIdpQFAU_9BCQ-hc9A4iP6JdxZvISE9cUaOeMt93juueM75yL01A5iQbkIrXhAAstl1LFi7jErkNqbfl8QEci1w8cnfvvcPex5vY3NnVLW0mLOavzT2nUl_2NV2Ad2latk_8Gy-UlhB7TBvrAFC8P2r2zc_ADv8sxQvhbfbTR3X1DJBMUEQulqp9OJs2QGeqqys3SpoWk6GcI4okzYklAYJVVnTc80SfnHucgTIg7god4Lmbqc9FWJhGpDjMezLAP0FJj4uxiOSEcrfXIcwOGv5dzvmYC_W1Rl8S8pASq_Esm5F62gDkedwbOCBx_NyvR5fzofKhUmhdjpUCyAcGsVKWDK7ZSlb4VZQHZYK01y9BbCrKcvZirYSH2KAmfNi0zodKoLTWrNBVNaXI2KZl79zag8TwIhtr2Uc_Ln0bgYeYFl-hZQW320KO0jtld2HbrAkHlFSMkPUPOEmlJQre214q20-i3Ap-YC0aKFS87SEE5eRa3zo6Oo2-x1N9EVAqGQrNJx0HmZzyPaodQ_8lQNRXPXmYCWTZ7n516mXSux1HJoprhV9wa6boIivK8RfhNtiOQWunps0j5uo2850HE6wC3-_SvOQI4lyC8vvmSgxSV472EDbuws9TCwvrz4bACNc7BiBdY9DHDGZTj_3AMXcMYSzljDGUs4YwNnDM0MzjiH8x103mp2G23LVCGxOK3XqUWZkKqdQK0dLwj80GO0LgIWxqEbBB7QfyYVkoIBY-Ar_RjiIWjEMnvaBQLKQ3oXbSVpIu4jTHzBOAQIfp8zt-_FLPTrJOR1xw78gQgHFfQsM1LEjUS_rBQzjrS4OInAnpGyZwXt5F0nWpdmXaftzNKRGbZmEfEJCT3PC50KepL_DE5FfimME5EuoA8EgeDs3dCvoHsaIflVqCtT6QiBm1WQ-fXlIwjJVePB7-_jIbpWvLDbaGs-XYhHQPXn7LHC-g8h7wH-
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Expansion+of+Fc%CE%B3+Receptor+IIIa%E2%80%93Positive+Macrophages%2C+Ficolin+1%E2%80%93Positive+Monocyte%E2%80%90Derived+Dendritic+Cells%2C+and+Plasmacytoid+Dendritic+Cells+Associated+With+Severe+Skin+Disease+in+Systemic+Sclerosis&rft.jtitle=Arthritis+%26+rheumatology+%28Hoboken%2C+N.J.%29&rft.au=Xue%2C+Dan&rft.au=Tabib%2C+Tracy&rft.au=Morse%2C+Christina&rft.au=Yang%2C+Yi&rft.date=2022-02-01&rft.pub=Wiley+Subscription+Services%2C+Inc&rft.issn=2326-5191&rft.eissn=2326-5205&rft.volume=74&rft.issue=2&rft.spage=329&rft.epage=341&rft_id=info:doi/10.1002%2Fart.41813&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2326-5191&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2326-5191&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2326-5191&client=summon